Clicky

PTC Therapeutics, Inc.(PTCT) News

Date Title
Jan 8 PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 42nd Annual J.P. Morgan Healthcare Conference
Jan 5 Strength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?
Jan 3 PTC Therapeutics to Participate at 42nd Annual J.P. Morgan Healthcare Conference
Dec 18 Biogen's (BIIB) Rare Disease Drug Skyclarys Gets CHMP Nod in EU
Dec 8 Solid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up
Dec 5 PTC Therapeutics Provides Updates on Translarna™ Regulatory Activities
Dec 5 PTC Therapeutics (NASDAQ:PTCT) shareholders are up 17% this past week, but still in the red over the last three years
Sep 19 Analysts on Wall Street Lower Ratings for These 10 Stocks
Sep 15 Biotech Crashes 30% After European Regulators Yank Approval For Muscle Disease Drug
Sep 15 CHMP Delivers Opinion on Translarna™ for Conversion to Full Authorization
Sep 12 Sensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of Directors
Sep 7 Is PTC Therapeutics (PTCT) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
Sep 7 Australian Patient Advocacy Organization Named a Recipient of PTC Therapeutics' 2023 STRIVE™ Award for Duchenne Muscular Dystrophy
Sep 7 PTC Therapeutics' 2023 STRIVE Awards Program Funds Initiatives Supporting the Duchenne Patient Community
Jul 18 PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 17 PTC Therapeutics Appoints Experienced Healthcare Finance Strategist Pierre Gravier as Chief Financial Officer
May 25 Biotech Stock Roundup: IRWD Announces Buyout, ICPT, SRPT & PTCT Fall on Updates
May 24 PTC Therapeutics' Barrage Of Bad News Is Good News For Rival Reata Pharmaceuticals — Here's Why
May 24 PTC Therapeutics' (PTCT) Rare Disease Drug Fails in Study
May 24 PTC Therapeutics Stock Tumbles: Company Stops Preclinical Gene Therapy Programs After Failed Friedreich's Ataxia Study